Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,090
-$1,344 QoQ
Shares Held
336
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2,749
of 2,821 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ramirez Asset Management, Inc. holds $30,805,111 across 7 Drug Manufacturers - General names. PFE ranks #6 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,509 | $18,601,961 | |
| 2 | ABBV |
AbbVie Inc.
|
23,922 | $6,019,732 | |
| 3 | AZN |
Astrazeneca PLC
|
30,192 | $5,725,007 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
5,016 | $289,021 | |
| 5 | JNJ |
Johnson & Johnson
|
626 | $158,985 | |
| 6 | PFE |
Pfizer Inc
This page
|
336 | $8,090 | |
| 7 | GRFS |
Grifols SA
|
327 | $2,315 |
All Filings in PFE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,090 | 336 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $9,434 | 336 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $20,816 | 836 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $21,301 | 836 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $20,264 | 836 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $25,846 | 1,020 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $48,284 | 1,820 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $52,670 | 1,820 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $64,913 | 2,320 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $64,380 | 2,320 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $66,792 | 2,320 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $76,954 | 2,320 | Shares | Sole | 2023-11-15 | |
| No filing history on record for this holder in this stock. | ||||||